598 / 1726
GUSTAVE ROUSSY
THÈME DU DIAPORAMA
Results
3-year PFS 74.4% Vs 69%
(p=0.029)
Median PFS- HR 0.68
Statistically significant
improvement in median
PFS
Conclusion
: Gemcitabine +
cisplatin CRT followed by
brachy & adjuvant gem/cis
CT improved survival
outcomes with increased but
clinically manageable toxicity
compared to standard Rx